# Sheldon X. Kong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sheldon-x-kong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,487 |
| Field | Diabetes Treatment and Management |
| h-index | 34 |
| i10-index | 67 |
| Last Known Institution | Bayer (United States) |
| OpenAlex ID | https://openalex.org/A5013645547 |
| ORCID iD | 0000-0002-8320-6930 |
| Works | 150 |

## Researcher papers

- [Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?](https://scholariq.org/papers/use-of-cost-effectiveness-analysis-in-health-care-resource-allocation-decision/)
- [A literature review of the epidemiology and treatment of acute gout](https://scholariq.org/papers/a-literature-review-of-the-epidemiology-and-treatment-of-acute-gout/)
- [Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system](https://scholariq.org/papers/prevalence-and-recognition-of-obesity-and-its-associated-comorbidities-cross/)
- [Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption](https://scholariq.org/papers/insomnia-health-related-quality-of-life-and-healthcare-resource-consumption/)
- [The SF-36 Health Survey as a Generic Outcome Measure in Clinical Trials of Patients With Osteoarthritis and Rheumatoid Arthritis](https://scholariq.org/papers/the-sf-36-health-survey-as-a-generic-outcome-measure-in-clinical-trials-of-2/)
- [The SF-36 Health Survey as a Generic Outcome Measure in Clinical Trials of Patients With Osteoarthritis and Rheumatoid Arthritis](https://scholariq.org/papers/the-sf-36-health-survey-as-a-generic-outcome-measure-in-clinical-trials-of/)
- [Rasch analysis of the Western Ontario MacMaster Questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia](https://scholariq.org/papers/rasch-analysis-of-the-western-ontario-macmaster-questionnaire-womac-in-2205/)
- [Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system](https://scholariq.org/papers/clinical-characteristics-complications-comorbidities-and-treatment-patterns/)
- [Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease](https://scholariq.org/papers/estimated-prevalence-and-testing-for-albuminuria-in-us-adults-at-risk-for/)
- [A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain](https://scholariq.org/papers/a-comprehensive-review-of-clinical-trials-on-the-efficacy-and-safety-of-drugs/)
- [Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors](https://scholariq.org/papers/development-of-clinical-prediction-models-for-renal-and-cardiovascular-outcomes/)
- [Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database](https://scholariq.org/papers/clinical-characteristics-and-disease-outcomes-in-non-diabetic-chronic-kidney/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

## Researcher university

- [Bayer (United States)](https://scholariq.org/institutions/bayer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
